Soleno Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
5.63 |
109.26 |
337.97 |
614.39 |
974.13 |
1,464.07 |
| Przychód Δ r/r |
0.00% |
1841.27% |
209.33% |
81.79% |
58.55% |
50.29% |
| Przychód (min) |
3.08 |
25.85 |
230.47 |
614.39 |
533.56 |
801.91 |
| Przychód (max) |
9.04 |
185.14 |
547.34 |
614.39 |
1,563.79 |
2,350.29 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-156.07 |
-72.36 |
64.53 |
290.24 |
369.28 |
582.15 |
| Zysk netto % |
-2773.01% |
-66.23% |
19.09% |
47.24% |
37.91% |
39.76% |
| EPS (średnia) |
-3.89 |
-1.80 |
1.63 |
5.49 |
9.19 |
14.49 |
| Liczba analityków (Przychody) |
6 |
7 |
9 |
6 |
2 |
5 |
| Liczba analityków (EPS) |
6 |
6 |
9 |
6 |
3 |
4 |
| symbol |
SLNO |
SLNO |
SLNO |
SLNO |
SLNO |
SLNO |